BrUs Jomid C amc w n(135) 72 160-163 x ©-c) 1995 Stoktn Pre Al rits rserved 0007-0920/95 $12.00 Differential CD44 expression patterns in primary brain tumours The samples used in this study were 27 brain metastases which originated from more than ten organs with different morphology (Table I) , 17 surgical specimens of glioblastomas, eight benign and two malignant meningomas, 13 neurinomas, 12 nmduloblastomas and four ependymomas.
Recently, a new member appeared in the list of metastasisrelated genes: CD44v, a series of isoforms of the lymphocyte homing receptor/epithelial adhesion molcule CD44. Its close correlation with metastasis was underlined by the abilty to confer metastatic potential on low or non-metastatic rat pancreatic cancer cells (Gunthert et al., 1991) and the high incidence of CD44v expresson in several types of human cancers and their metastases (Hofmann et al., 1991; Matsumura and Tarin, 1992; Heider et al., 1993a,b) . So far, the underlying mechanisn of CD44v-mediated astais is largely uninown, but it is hypothesised that metastatic cells with CD44v expression mimic crculating lymphocytes during their dissinaton to lymph nodes (Arch et al., 1992) , allowing metastasing tumour cell to bind to a not yet identified ligand in the distant blood and lymphatic vessels.
In the literature, most studies concerning CD44v expression in human cancer cells and its correlation with metastasis have been performed on adenocarcinomas of the breast, colon and stomach (Matsumura and Tarin, 1992; Heider et al., 1993a , Mayer et al., 1993 Wielenga et al., 1993) . We reported previously the absence of CD44v expression in highly invasive but rarely metastatic glioblastomas (Li et al., 1993 The samples used in this study were 27 brain metastases which originated from more than ten organs with different morphology (Table I) , 17 surgical specimens of glioblastomas, eight benign and two malignant meningomas, 13 neurinomas, 12 nmduloblastomas and four ependymomas.
The tumour samples were collected directly from the operation room, and parts of the tumours were frozen in liquid nitrogen within 2 h of removal, and stored at -70-C until use. The emnaining parts were fixed in 10% buffered formain, and embedded in paraffin for conventional histopathological examination.
RNA isoation and analyses
Total celular RNA was isolated from the tumour sampls and cell lines by the method of Chomczynski and Sacchi (1987) . Northern blot analysis was done with a 1.5 kb cDNA probe encompassing both standard and variant CD44 sequences (Hofnann et al., 1991) . A spontaneously immortalised human keratinocyte line, HaCat (Hofmann et al., 1991) , was used as positive control for splicing variants of CD44 in the experiments.
To confirm the results from Northern analysis, RNA samplesex racted from 22 brain metastases (BMTs) and some representative cases of each kid of pinmary brain tumours (PBTs) were subjected to RT-PCR. Random primers were used for first-stad cDNA synthesis and sense upstream (5'-CAGACCTGCCCAATGCCTITGATGGGAC) and antisense downstream (5'-CAAAGCCAAGGCCAAGAGGGC-TGCC) prmers were used for PCR amplfication. These primers flank-the highly variable extracellular region, where additional exons can be 'inserted' by alternative spling (Tolg et al., 1993) . The reverse transcription reaction was performed at 3TC for 60min, followed by incubation at 95C for 5 min to inactivate the reverse transcriptase. PCR was done with the following parameters: 94 C for 5 min, then Table II .
In parallel with the data of Northern blot hybridisation, the results of RT-PCR (Figure 1) v5-vlO (Figure 2a ), six were positive for exons v5-v7 but not for exons v8-vlO ( Figure  2b ) and three were positive for exons v8-vlO but almost negative for exons v5-v7 (Figure 2c ). These results are in good agreement with those obtained in Northern and RT-PCR analyses (Table II) According to the literature, CD44v is expressed constitutively in squamous ceUs of normal bronchial, cervical and tonsil mucosa, but not in normal epithelial cells in the colon, lung and breast (Heider et al., 1993a; Mackay et al., 1994) , demonstrating a cell type-specific expression of CD44v in normal epithelial cells. In contrast, CD44v becomes detectable in metastatic tumours including brain metastases formed by adenocarctnomas of the breast (6/6), the lung (3/4) and digestive tract (2/2), supporting the idea that CD44v expression is acquired during progression of human adenocarcinomas (Heider et al., 1993b (Salmi et al., 1993) .
As shown in Table II exons may be the structural and even functional core part of CD44v. Absence of CD44s and CD44v expression in the remaining 16% of brain metastases formed by small-cell lung cancers, adenocarcinomas of the lungs and kidney implies the existence of CD44v-independent metastatic pathways which may be mediated by other genetic alterations.
In summary, our data present direct evidence for general distribution of CD44v in various kinds of human tumours metastasising to the brain and show that expression of CD44v is an extremely rare event in five types of PBTs, indicating that CD44v may be one of the important elements for tumour cells to metastasise.
Abbreviatios: CD44s, standard form of CD44; CD44v, splicing variants of CD44; RT-PCR, reverse transcription-polymerase chain reaction.
